AI ASSISTANT
Ask DrugCentral
Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIYour question
Ask in your own words. Each question is answered independently.
Explore sample questions
Select a question to fill the editor, then ask it or make it your own.
DrugCentral answer
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
About Ask DrugCentral
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
General architecture
- Ask a questionThe browser sends your question to the same-origin Django chat API.
- Retrieve and generateThe API forwards the question to the configured DrugCentral retrieval-augmented generation (RAG) service, which returns an AI-generated answer.
- Explore the answerThe app resolves cited drug-card names and displays the answer with links to drug records.
Using the assistant
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
resorcinol 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 3524 | 108-46-3 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
an antiseptic and disinfectant used for temporary relief of itching
|
Drug dosage:
None
ADMET properties:
None
Predicted pharmacokinetic/toxicological properties (PK-AZ):
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| kinase-safety-class | ACVR2A,ACVR2B,ACVRL1,AKT3,ALK,AURKA,AURKB,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK1,CDK4,CDK5,CDK9,CHEK1,CSF1R,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GSK3B,IRAK1,ITK,JAK1,JAK2,KIT,MAP2K6,MAP3K1,MAP3K10,MAP3K11,MAP3K14,MAP3K21,MAP3K7,MAP4K1,MAP4K3,MAPK10,MAPK12,MAPK7,MAPK9,MAPKAPK2,MARK4,MTOR,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CA,PIK3CB,PIK3CD,PIM2,PRKCD,PRKDC,SGK1,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ULK1,ULK2 | 69 | |||
| kinase-selectivity-class | ACVR2A,ACVR2B,AXL,BRAF,CAMK2D,CDK9,DDR1,DYRK1B,GRK2,MAP2K6,MAP3K21,MAPK7,PIK3CB,PIK3CD,PRKDC,SIK2,SIK3,STK33,TGFBR1,TTK,ULK1 | 21 | |||
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | D10AX02 | DERMATOLOGICALS ANTI-ACNE PREPARATIONS ANTI-ACNE PREPARATIONS FOR TOPICAL USE Other anti-acne preparations for topical use |
| ATC | S01AX06 | SENSORY ORGANS OPHTHALMOLOGICALS ANTIINFECTIVES Other antiinfectives |
| CHEBI has role | CHEBI:66981 | ophthalmology drug |
| CHEBI has role | CHEBI:91025 | erythropoietin inhibitor |
| CHEBI has role | CHEBI:139492 | sensitiser |
Related Drugs by ATC class:
D10AX Other anti-acne preparations for topical use 5 drugs
S01AX Other antiinfectives 13 drugs
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Acne vulgaris | indication | 88616000 | |
| Skin irritation | indication | 367466007 | |
| Acneiform eruption | indication | 402644006 | |
| Itching of skin | indication | 418363000 | |
| Minor Skin Wound Pain | indication | ||
| Folliculitis | contraindication | 13600006 | DOID:4409 |
| Infection of skin AND/OR subcutaneous tissue | contraindication | 19824006 | |
| Methemoglobinemia | contraindication | 38959009 | DOID:10783 |
| Conduction disorder of the heart | contraindication | 44808001 | |
| Diabetes mellitus | contraindication | 73211009 | DOID:9351 |
| Decreased respiratory function | contraindication | 80954004 | |
| Kidney disease | contraindication | 90708001 | DOID:557 |
| Anemia due to enzyme deficiency | contraindication | 111577008 | |
| Deficiency of glucose-6-phosphate dehydrogenase | contraindication | 124134002 | DOID:2862 |
| Deficiency of cytochrome-b>5< reductase | contraindication | 124184009 | |
| Open wound | contraindication | 125643001 | |
| Seizure disorder | contraindication | 128613002 | |
| Condyloma acuminatum | contraindication | 240542006 | DOID:11168 |
| Eruption of skin | contraindication | 271807003 | DOID:0050486 |
| Peripheral vascular disease | contraindication | 400047006 | |
| Blister | contraindication | 417237009 | |
| Denuded skin | contraindication | 418242004 | |
| Inflammatory dermatosis | contraindication | 703938007 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 9.01 | acidic |
| pKa2 | 11.02 | acidic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Carbonic anhydrase 2 | Enzyme | Ki | 5.11 | CHEMBL | |||||
| Carbonic anhydrase 9 | Enzyme | Ki | 4.16 | CHEMBL | |||||
| Carbonic anhydrase 12 | Enzyme | Ki | 5.12 | CHEMBL | |||||
| Carbonic anhydrase 5A, mitochondrial | Enzyme | Ki | 5.06 | CHEMBL | |||||
| Carbonic anhydrase 5B, mitochondrial | Enzyme | Ki | 5.15 | CHEMBL | |||||
| Carbonic anhydrase 14 | Enzyme | Ki | 4.97 | CHEMBL | |||||
| Carbonic anhydrase 13 | Enzyme | Ki | 4.20 | CHEMBL | |||||
| Prostaglandin G/H synthase 1 | Enzyme | Kd | 4.06 | CHEMBL | |||||
| Carbonic anhydrase | Enzyme | Ki | 5.19 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| YUL4LO94HK | UNII |
| 4019032 | VUID |
| N0000147303 | NUI |
| D00133 | KEGG_DRUG |
| 4019032 | VANDF |
| C0073085 | UMLSCUI |
| CHEBI:27810 | CHEBI |
| RCO | PDB_CHEM_ID |
| CHEMBL24147 | ChEMBL_ID |
| 5054 | PUBCHEM_CID |
| DB11085 | DRUGBANK_ID |
| C031389 | MESH_SUPPLEMENTAL_RECORD_UI |
| 35382 | RXNORM |
| 5052 | MMSL |
| 5418 | MMSL |
| 001950 | NDDF |
| 411296008 | SNOMEDCT_US |
| 78032005 | SNOMEDCT_US |
| YUL4LO94HK | INXIGHT DRUGS |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Anti-Itch Regular Strength | HUMAN OTC DRUG LABEL | 2 | 0363-0621 | CREAM | 2 g | TOPICAL | OTC monograph final | 11 sections |
| Well at Walgreens Anti-Itch Maximum Strength | HUMAN OTC DRUG LABEL | 2 | 0363-0674 | CREAM | 3 g | TOPICAL | OTC monograph final | 11 sections |
| Anti-Itch Medicated Maximum Strength | HUMAN OTC DRUG LABEL | 2 | 0363-2311 | CREAM | 30 mg | TOPICAL | OTC Monograph Drug | 11 sections |
| Tinted Acne Treatment | HUMAN OTC DRUG LABEL | 2 | 0363-7783 | CREAM | 2 g | TOPICAL | OTC monograph final | 7 sections |
| REZAMID | HUMAN OTC DRUG LABEL | 2 | 11086-022 | LOTION | 2 g | TOPICAL | OTC Monograph Drug | 11 sections |
| VAGISIL Anti-Itch Medicated Creme Maximum Strength | HUMAN OTC DRUG LABEL | 2 | 11509-4402 | CREAM | 30 mg | TOPICAL | OTC Monograph Drug | 11 sections |
| VAGISIL Anti-Itch Creme Regular Strength | HUMAN OTC DRUG LABEL | 2 | 11509-5103 | CREAM | 20 mg | TOPICAL | OTC Monograph Drug | 10 sections |
| BENZOCAINE and RESORCINOL | HUMAN OTC DRUG LABEL | 2 | 11822-2890 | OINTMENT | 20 mg | TOPICAL | OTC monograph not final | 7 sections |
| Rite Aid Original Strength Vagicaine | HUMAN OTC DRUG LABEL | 2 | 11822-2891 | CREAM | 20 mg | TOPICAL | OTC monograph not final | 7 sections |
| Vagicaine Medicated Maximum Strength | HUMAN OTC DRUG LABEL | 2 | 11822-5880 | CREAM | 30 mg | TOPICAL | OTC Monograph Drug | 11 sections |
| Rite Aid Original Strength Vagicaine | HUMAN OTC DRUG LABEL | 2 | 11822-9974 | CREAM | 2 g | TOPICAL | OTC monograph not final | 9 sections |
| Budpak Feminine Anti-Itch | HUMAN OTC DRUG LABEL | 2 | 27293-022 | CREAM | 0.02 g | TOPICAL | OTC monograph not final | 10 sections |
| Vagicaine | HUMAN OTC DRUG LABEL | 2 | 29500-7820 | CREAM | 0.85 g | TOPICAL | OTC monograph not final | 12 sections |
| AssuredFeminine Anti-itch | HUMAN OTC DRUG LABEL | 2 | 33992-2014 | CREAM | 2 g | TOPICAL | OTC monograph not final | 10 sections |
| Well at Walgreens Anti-ItchMaximum Strength | HUMAN OTC DRUG LABEL | 2 | 47046-181 | CREAM | 3 g | TOPICAL | OTC monograph final | 11 sections |
| Stage Fight Acne Mask | HUMAN OTC DRUG LABEL | 2 | 49825-137 | PASTE | 2 g | TOPICAL | OTC Monograph Drug | 8 sections |
| Family Wellness | HUMAN OTC DRUG LABEL | 2 | 55621-016 | CREAM | 3 g | TOPICAL | OTC Monograph Drug | 9 sections |
| BENZOCAINE and RESORCINOL | HUMAN OTC DRUG LABEL | 2 | 55910-185 | CREAM | 20 mg | TOPICAL | OTC monograph not final | 7 sections |
| REXALL FEMININE MAXIMUM STRENGTH ANTI-ITCH | HUMAN OTC DRUG LABEL | 2 | 55910-415 | CREAM | 3 g | TOPICAL | OTC monograph final | 11 sections |
| Stage Fight Acne Mask | HUMAN OTC DRUG LABEL | 2 | 56152-0254 | PASTE | 2 g | TOPICAL | OTC Monograph Drug | 8 sections |
| Stage Fight Acne Mask | HUMAN OTC DRUG LABEL | 2 | 56152-0254 | PASTE | 2 g | TOPICAL | OTC Monograph Drug | 8 sections |
| Vagicaine Maximum Strength Anti-Itch Cream | HUMAN OTC DRUG LABEL | 2 | 59779-588 | CREAM | 0.84 g | TOPICAL | OTC monograph not final | 12 sections |
| BENZOCAINE and RESORCINOL | HUMAN OTC DRUG LABEL | 2 | 59779-810 | CREAM | 20 mg | TOPICAL | OTC monograph not final | 7 sections |
| CVS ACNE TREATMENT | HUMAN OTC DRUG LABEL | 2 | 59779-813 | CREAM | 20 mg | TOPICAL | OTC monograph not final | 7 sections |
| Feminine Anti-Itch Creme | HUMAN OTC DRUG LABEL | 2 | 63868-949 | CREAM | 0.85 g | TOPICAL | OTC Monograph Drug | 12 sections |
| Feminine Anti-Itch Creme | HUMAN OTC DRUG LABEL | 2 | 63868-949 | CREAM | 0.85 g | TOPICAL | OTC Monograph Drug | 12 sections |
| Resinol | HUMAN OTC DRUG LABEL | 2 | 67492-105 | OINTMENT | 2 g | TOPICAL | OTC monograph drug | 13 sections |
| BENZOCAINE and RESORCINOL | HUMAN OTC DRUG LABEL | 2 | 67868-117 | CREAM | 20 mg | TOPICAL | OTC monograph not final | 7 sections |
| Feminine Anti Itch Cream | HUMAN OTC DRUG LABEL | 2 | 69396-183 | CREAM | 3 g | TOPICAL | OTC Monograph Drug | 12 sections |
| Acne Treatment maximum strengthCVS | HUMAN OTC DRUG LABEL | 2 | 69842-046 | CREAM | 2 g | TOPICAL | OTC monograph final | 7 sections |